|
Q4 2024
|
6 |
120,193 |
ALMS, HIMS, CGON, IRON
|
13F-HR
|
2/14/2025 |
000110465925013930 |
|
Q3 2024
|
5 |
143,892 |
ALMS, HIMS, CGON, IRON
|
13F-HR
|
11/14/2024 |
000110465924118745 |
|
Q2 2024
|
5 |
156,616 |
Alumis Inc, HIMS, CGON, IRON
|
13F-HR
|
8/13/2024 |
000110465924088866 |
|
Q1 2024
|
5 |
106,531 |
HIMS, CG Oncology, Inc., IRON, KNTE
|
13F-HR
|
5/15/2024 |
000110465924061748 |
|
Q4 2023
|
5 |
73,391 |
HIMS, THRX, IRON, KNTE
|
13F-HR
|
2/13/2024 |
000110465924019707 |
|
Q3 2023
|
7 |
62,679 |
HIMS, IRON, THRX, ACRS
|
13F-HR
|
11/13/2023 |
000110465923117294 |
|
Q2 2023
|
10 |
136,901 |
HIMS, THRX, PRDS, ACRS
|
13F-HR
|
8/11/2023 |
000110465923090058 |
|
Q1 2023
|
11 |
135,274 |
HIMS, THRX, PRDS, KNTE
|
13F-HR
|
5/12/2023 |
000110465923059499 |
|
Q4 2022
|
11 |
128,750 |
HIMS, CMPX, ACRS, THRX
|
13F-HR
|
2/13/2023 |
000110465923019781 |
|
Q3 2022
|
14 |
130,057 |
ACRS, THRX, HIMS, PRDS
|
13F-HR
|
11/14/2022 |
000110465922117993 |
|
Q2 2022
|
14 |
143,141 |
PRDS, THRX, ACRS, SLGC
|
13F-HR
|
8/12/2022 |
000110465922089769 |
|
Q1 2022
|
17 |
244,877 |
PRDS, THRX, SLGC, ACRS
|
13F-HR
|
5/13/2022 |
000110465922059939 |
|
Q4 2021
|
16 |
407,014 |
PRDS, SLGC, THRX, QSI
|
13F-HR
|
2/11/2022 |
000110465922020352 |
|
Q3 2021
|
17 |
321,757 |
SLGC, CGEM, IVVD, ACRS
|
13F-HR
|
11/12/2021 |
000110465921137703 |
|
Q2 2021
|
17 |
254,189 |
CGEM, QSI, ACRS, KNTE
|
13F-HR
|
8/16/2021 |
000110465921105290 |
|
Q1 2021
|
20 |
340,170 |
CGEM, Gemini Therapeutics, Inc., ACRS, KNTE
|
13F-HR
|
5/17/2021 |
000110465921067104 |
|
Q4 2020
|
12 |
135,028 |
KNTE, ALXO, RLAY, NRIX
|
13F-HR
|
2/16/2021 |
000110465921023088 |